PAHC
PAHC
NASDAQ · Pharmaceuticals

Phibro Animal Health Corp-A

$37.15
+0.82 (+2.26%)
As of Aug 8, 1:34 AM ET ·
Analyst Consensus
Strong Sell
10
Analysts
Moderate
Coverage
Buy 1 10%
Hold 5 50%
Sell 4 40%
Price Target
Analyst Price Target +189.9% upside
Low Target $71.95
Average Target $107.71
High Target $157.72
Current Price $37.15
Current
$37.15
Target
$107.71
$71.95 $107.71 avg $157.72
Scenario Analysis
Bear Case
$71.95
93.7%
Low target
Base Case
$107.71
+189.9%
Avg target
Bull Case
$157.72
+324.5%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$60.08
-38.2% from high
52-Week Low
$26.08
+42.4% from low
50-Day SMA
$42.00
-11.5% vs SMA
200-Day SMA
$35.40
+4.9% vs SMA
RSI (14)
80.2
Overbought
Target vs 52W High
$107.71
+79.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%